| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3474818 | Italian Journal of Medicine | 2011 | 7 Pages |
Abstract
Apixaban is a promising new oral anticoagulant. However, additional studies on effectiveness and safety are needed to determine whether it can compete with the coumarins in the prevention and treatment of thromboembolic diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gianluca Airoldi, Mauro Campanini,